Journals / Journal of Clinical and Experimental Investigations / 2014 / Cilt: 5 - Sayı: 3

İdrar interlökin-13, CD80, CD28, matriks metaloproteinaz-2 ve granzim B'nin çocukluk çağı minimal değişim nefrotik sendrom patogenezindeki rolleri

The roles of urine interleukin-13, CD80, CD28, matrix metalloproteinase-2 and granzyme B in the pathogenesis of childhood minimal change nephrotic syndrome

Pages
354–361
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significant positive correlation between the active-stage urine interleukin-13 and CD80 levels (r=0.619, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Minimal change disease (MCD) is the most common cause of nephrotic syndrome in childhood but its pathogenesis remains poorly understood.
📊
Key Findings & Data:However, podocyte CD80 expression is now a commonly discussed theory.
💡
Conclusion & Impact:There was a significant positive correlation between the active-stage urine interleukin-13 and CD80 levels (r=0.619, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Minimal change disease (MCD) is the most common cause of nephrotic syndrome in childhood but its pathogenesis remains poorly understood. A T-cell-derived factor or factors were initially alleged as contributing to the disease pathogenesis. However, podocyte CD80 expression is now a commonly discussed theory. The aim of this study was to investigate the pathogenesis of MCD by determining urine interleukin-13, CD80, CD28, matrix metalloproteinase-2 (MMP-2), and granzyme B levels. Methods: Thirty patients and thirty healthy children were evaluated in this study. Six patients had biopsy proven MCD. The remaining patients were considered to have MCD because of their age at time of diagnosis; response to steroid treatment, absence of gross hematuria, hypocomplementemia or renal failure; and normal blood pressures in the active stage. The nephrotic-phase urine interleukin-13, CD80, CD28, MMP-2, and granzyme B levels of all patients were compared with the remission-stage urine levels of the same patients and control subjects. The urine samples were collected immediately before the application of immunosuppressive drugs or other treatment modalities.Results: Significantly higher interleukin-13, CD80, CD28, and MMP-2 levels were observed in the relapse period compared with both the remission period and control subjects. There was a significant positive correlation between the active-stage urine interleukin-13 and CD80 levels (r=0.619, p

Özet

Amaç: Minimal değişiklik hastalığı çocuklarda nefrotik sendromun en sık nedenidir ve patogenezi hala aydınlatılamamıştır. Başlangıçta T hücresi kaynaklı faktör ya da faktörlerin hastalığın patogenezinden sorumlu olduğu ileri sürülmüştür. Fakat günümüzde hastalığın patogenezinde podosit CD80 ekspresyonu ön plana çıkmıştır. Bizim bu çalışmada amacımız hastaların idrar interlökin-13, CD80, CD28, matriks metaloproteinaz-2 ve granzim b düzeylerine bakarak hastalığın patogenezini anlamaya çalışmaktır. Yöntemler: Bu amaçla 30 hasta ve 30 sağlıklı çocuktan oluşan kontrol grubu ile çalıştık. 6 hastanın biyopsi sonucu minimal değişiklik hastalığı idi. Diğer hastalara hastalığın ilk aktif dönemindeki başlangıç yaşı, steroid tedavisine verdikleri cevap, hastalığın tanısı sırasında gros hematüri, hipokomplementemi, renal yetmezlik ve hipertansiyon olmaması nedeniyle minimal değişiklik hastalığı tanısı konuldu. Hastaların aktif faz idrar interlökin-13, CD80, CD28, matriks metaloproteinaz-2 ve granzim b düzeyleri aynı hastaların remisyon dönemi ve kontrol grubu ile karşılaştırıldı. İmmünsüpresif ilaçlar ya da diğer tedavi modaliteleri başlamadan hemen önce idrar örnekleri alındı.Bulgular: Hastalığın aktif döneminde remisyon ve kontrol grubuna göre istatistiksel olarak anlamlı idrar interlökin-13, CD80, CD28 ve MMP-2 yüksekliği saptadık. Nefrotik faz idrar interlökin-13 düzeyleri ile CD80 düzeyleri arasında pozitif korelasyon mevcuttu (r=0,619, p

🔖

Cite This Article

KAVAZ, A., BULUM, B., GÜLLEROĞLU, K., HACIHAMDİOĞLU, D. Ö., YALÇINKAYA, F., BASKIN, E., MUŞABAK, U., PEKEL, A., KANTAR, A., AKGÜN, C., YAVUZ, S. T., ZEYBEK, C., GÖK, F. (2022). İdrar interlökin-13, CD80, CD28, matriks metaloproteinaz-2 ve granzim B'nin çocukluk çağı minimal değişim nefrotik sendrom patogenezindeki rolleri. Journal of Clinical and Experimental Investigations, Cilt: 5 - Sayı: 3, 354–361. https://ajindex.com/articles/561779

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Niaudet P, Boyer O. Idiopathic Nephrotic Syndrome in Children: Clinical Aspects. In Ellis D. Avner (ed.) Pedi- atric Nephrology. 6th ed. Springer-Verlag, Heidelberg; 2009, pp 667-702. Shalhoub RJ. Pathogenesis of lipoid nephrosis: A dis- order of T cell function. Lancet 1974;2:556-560.
  2. Tejani AT, Butt K, Trachtman H, et al. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988;33:729-734.
  3. Ali AA, Wilson E, Moorhead JF, et al. Minimal change glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation 1994;58:849-852.
  4. Koyama A, Fujisaki M, Kobayashi M, et al. A glomeruler permeability factor produced by human T cell hybrid- omas. Kidney Int 1991; 40: 453-460.
  5. Lagrue G, Laurent J. Allergy and lipoid nephrosis. Adv Nephrol Necker Hosp 1983;12:151-175.
  6. Yokoyama H, Kida H, Tani Y, et al. Immunodynamics of minimal change nephrotic syndrome in adults T and B lymphocyte subsets and serum Ig levels. Clin Exp Immunol 1985;61:601-607.
  7. Izuhara K, Arima K, Yasunaga S, et al. IL-4 and IL-13: Their pathological roles in allergic diseases and their potential in developing new therapies. Curr Drug Tar- gets Inflamm Allergy 2002;1:263-269.
  8. Lai KW, Wei CL, Tan LK, et al. Overexpression of inter- leukin-13 induces minimal change like nephropathy in rats. J Am Soc Nephrol 2007;18:1476-1485. Reiser J, von Gersdorff G, Loos M, et al. Induction of B7-1 in podocytes is associated with nephrotic syn- drome. J Clin Invest 2004;113:1390-1397.
  9. Garin EH, Diaz LN, Mu W, et al. Urinary CD80 excre- tion increases in idiopathic minimal change disease. J Am Soc Nephrol 2009;20:260-266.
  10. Garin E, Mu W, Arthur JM, et al. Urinary CD80 is el- evated in minimal change disease but not in focal seg- mental glomerulosclerosis. Kidney Int 2010;78:296- 302. Abbas AK, Lichtman AH, Pillai S. Cellular and Mo- lecular Immunology. Saunders Elsevier, Philadelphia; 2010, pp 194-198.
  11. Urushihara M, Kagami S, Kuhara T, et al. Glomerular distribution and gelatinolytic activity of matrix metal- loproteinases in human glomerulonephritis. Nephrol Dial Transplant. 2002;17:1189-1196.
  12. Wasilewska AM, Zoch-Zwiers WM. Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children. Pediatr Nephrol 2008;23:1795- 1802. Czech AK, Bennett M, Devarajan P. Distinct metallo- proteinase excretion patterns in focal segmental glo- merulosclerosis. Pediatr Nephrol 2011;26:2179-2184.
  13. Afonina I, Cullen S, Martin SJ. Cytotoxic and non- cytotoxic